PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120-Reference-Cited by-同舟云学术

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

Published:2022-09 Issue: Volume:83 Page:104224
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Fazio Grazia^ORCID,Bresolin Silvia,Silvestri Daniela,Quadri Manuel,Saitta Claudia^ORCID,Vendramini Elena,Buldini Barbara,Palmi Chiara^ORCID,Bardini Michela,Grioni Andrea,Rigamonti Silvia,Galbiati Marta,Mecca Stefano,Savino Angela Maria,Peloso Alberto,Tu Jia-Wey,Bhatia Sanil^ORCID,Borkhardt Arndt,Micalizzi Concetta^ORCID,Lo Nigro Luca,Locatelli Franco,Conter Valentino,Rizzari Carmelo,Valsecchi Maria Grazia,te Kronnie Geertruij^ORCID,Biondi Andrea,Cazzaniga Giovanni

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference40 articles.

1. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study;Den Boer;Lancet Oncol,2009

2. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia;Mullighan;N Engl J Med,2009

3. Philadelphia chromosome-like acute lymphoblastic leukemia;Pui;Clin Lymphoma Myeloma Leuk,2017

4. The current genomic and molecular landscape of Philadelphia-like acute lymphoblastic leukemia;Shiraz;Int J Mol Sci,2020

5. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning approaches to identify systemic lupus erythematosus in anti-nuclear antibody-positive patients using genomic data and electronic health records;BioData Mining;2024-01-05

2. Novel Biomarkers and Molecular Targets in ALL;Current Hematologic Malignancy Reports;2023-12-04

3. High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia;Biochemical Pharmacology;2023-11

4. Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia;HemaSphere;2023-06-22

5. Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia;HemaSphere;2023-05-26